[Form 4] Weyco Group Inc Insider Trading Activity

Rhea-AI Filing Summary

John W. Florsheim, President and COO and a director of Weyco Group Inc. (WEYS), reported transactions on 08/19/2025. The filing shows a direct disposition of 3,870 shares and contemporaneous acquisitions of 3,870 shares reported as indirect holdings through trusts and family relationships. Following the reported transactions, Mr. Florsheim directly beneficially owns 425,958 shares and indirectly owns multiple blocks totaling 314,484 shares as trustee, 94,619 shares in an irrevocable trust, 74,476 shares held by his wife, and 221,873 shares in a family trust. The form also lists outstanding stock options exercisable into common stock (totaling 42,000 shares across five grants) with exercise prices and expiration dates shown. The report is signed and dated 08/20/2025.

Positive

• Complete disclosure: The filing itemizes direct and indirect holdings, option grants, exercise prices, and vesting/expiration information.
• Timely reporting: Transactions dated 08/19/2025 and form signed 08/20/2025 indicate prompt Section 16 reporting.
• Substantial insider ownership: Reporter retains large direct (425,958) and significant indirect holdings across trusts and family accounts.

Negative

• Insider sale reported: A direct disposition of 3,870 shares was executed on 08/19/2025.
• Concentrated ownership: Significant indirect holdings via trusts and family may concentrate voting and economic control (documented amounts).

Insights

Securities Analyst

TL;DR: Insider reported a small direct sale and matching indirect acquisition, while retaining substantial direct and indirect ownership plus option positions.

The Form 4 shows a same-day direct disposition of 3,870 shares (Code G) and matching acquisitions of 3,870 shares recorded as indirect holdings. The reporter remains a large insider with 425,958 shares direct and multiple indirect blocks (totaling specific trustee, trust and spouse-held amounts). The filing details five option grants totaling 42,000 underlying shares with exercise prices from $18.00 to $37.22 and staggered expiration dates through 2033. For investors, this is a routine Section 16 disclosure documenting ownership structure and option exposure rather than a standalone signal of material corporate change.

Corporate Governance Expert

TL;DR: Disclosure is complete and timely; structure shows concentrated insider ownership and multi-party indirect holdings via trusts.

The Form 4 provides clear attribution of direct versus indirect holdings and specifies the nature of indirect ownership (trustee, irrevocable trust, spouse, family trust). The explanation section clarifies option vesting schedules (20% per year over five years for referenced grants). Such detailed reporting supports governance transparency and allows stakeholders to track how control and economic interests are allocated among family and trust vehicles.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FLORSHEIM JOHN W

(Last) (First) (Middle)

333 W. ESTABROOK BOULEVARD

(Street)

GLENDALE WI 53212

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WEYCO GROUP INC [ WEYS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT AND COO

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2025		G		3,870	D	$0	425,958	D
Common Stock	08/19/2025		G		3,870	A	$0	314,484	I	As Trustee for Children
Common Stock								94,619	I	Held in 2018 Irrevocable Trust
Common Stock								74,476	I	By Wife
Common Stock								221,873	I(1)	John Florsheim Family Trust of which Brother is Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$37.22							08/23/2019(2)	08/23/2028	Common Stock	8,000		8,000	D
Stock Option	$18							08/26/2021(3)	08/26/2030	Common Stock	10,000		10,000	D
Stock Option	$24							08/25/2022(4)	08/25/2031	Common Stock	10,000		10,000	D
Stock Option	$28.83							08/25/2023(5)	08/25/2032	Common Stock	7,000		7,000	D
Stock Option	$25.79							08/25/2024(6)	08/25/2033	Common Stock	7,000		7,000	D

Explanation of Responses:

1. For informational purposes only

2. 20% per year for 5 years beginning 08/23/2019

3. 20% per year for 5 years beginning 08/26/2021

4. 20% per year for 5 years beginning 08/25/2022

5. 20% per year for 5 years beginning 08/25/2023

6. 20% per year for 5 years beginning 08/25/2024

	/s/ John W. Florsheim	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did WEYS reporting person John W. Florsheim report on 08/19/2025?

The Form 4 reports a direct disposition of 3,870 shares and acquisitions of 3,870 shares recorded as indirect holdings on 08/19/2025.

How many WEYS shares does John W. Florsheim directly and indirectly own after the reported transactions?

Following the transactions the filing shows 425,958 shares directly and indirect holdings including 314,484 (as trustee), 94,619 (2018 irrevocable trust), 74,476 (by wife) and 221,873 (family trust) as reported.

What stock options does John W. Florsheim hold in WEYS according to the Form 4?

The filing lists five option grants exercisable into common stock totaling 42,000 underlying shares with exercise prices of $37.22, $18.00, $24.00, $28.83, and $25.79 and expirations through 2033.

Does the Form 4 explain option vesting schedules for the reported grants?

Yes. The explanations state the grants vest at 20% per year for five years beginning on the listed grant dates.

When was the Form 4 signed and filed?

The signature block shows the form was signed by John W. Florsheim on 08/20/2025.